Moderna
MRNA
#1187
Rank
A$24.32 B
Marketcap
$63.21
Share price
7.48%
Change (1 day)
-47.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -A$6.6 Billion

According to Moderna 's latest financial reports the company's current earnings are A$4.98 Billion. In 2023 the company made an earning of -A$6.01 Billion a decrease over its 2022 earnings that were of A$14.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$6.6 Billion9.94%
2023 -A$6.01 Billion-140.65%
2022 A$14.76 B-27.81%
2021 A$20.45 B-1911.15%
2020 -A$1.13 Billion44.7%
2019 -A$0.79 Billion28.63%
2018 -A$0.61 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$53.82 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.35 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$64.22 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.29 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.57 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-A$0.81 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.28 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA